Interaction with azole prophylaxis in AML17. (A) Azole vs not; (B) by type of azole; (C) survival in patients given concomitant GO and azoles. CR: complete remission; CRi: complete remission with incomplete peripheral count recovery; GO: gemtuzumab ozogamicin